Sanara MedTech Inc. (SMTI) stock
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30144% above fair value
$32.73−0.03 (-0.09%)
Close on Nov 17, 2026Market cap $300.72MP/E –Yield –
Sanara MedTech operating margin
Operating margin is operating income as a percentage of revenue.
Sanara MedTech's operating margin for the twelve months ending Jun 30, 2026 was 7.7%. For fiscal 2025 it was 7.1%, against 1.5% the year before. The highest annual figure on record is 7.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.1% | +5.6 |
| FY2024 | Dec 31, 2024 | 1.5% | +7.9 |
| FY2023 | Dec 31, 2023 | -6.5% | +20.8 |
| FY2022 | Dec 31, 2022 | -27.3% | +3.2 |
| FY2021 | Dec 31, 2021 | -30.6% | +1.7 |
| FY2020 | Dec 31, 2020 | -32.3% | −9.0 |
| FY2019 | Dec 31, 2019 | -23.3% | −14.7 |
| FY2018 | Dec 31, 2018 | -8.6% | −10.5 |
| FY2017 | Dec 31, 2017 | 1.9% | +6.9 |
| FY2016 | Dec 31, 2016 | -4.9% | +23.7 |
| FY2015 | Dec 31, 2015 | -28.6% | +198.3 |
| FY2011 | Dec 31, 2011 | -226.9% | +45.0 |
| FY2010 | Dec 31, 2010 | -271.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 6.3% | −3.3 |
| Q1 FY2026 | Mar 31, 2026 | 9.5% | +6.0 |
| Q4 FY2025 | Dec 31, 2025 | 3.8% | −4.8 |
| Q3 FY2025 | Sep 30, 2025 | 11.2% | +7.6 |
| Q2 FY2025 | Jun 30, 2025 | 9.6% | +23.9 |
| Q1 FY2025 | Mar 31, 2025 | 3.5% | +11.8 |
| Q4 FY2024 | Dec 31, 2024 | 8.6% | +9.9 |
| Q3 FY2024 | Sep 30, 2024 | 3.6% | +9.3 |
| Q2 FY2024 | Jun 30, 2024 | -14.3% | −2.5 |
| Q1 FY2024 | Mar 31, 2024 | -8.3% | −0.4 |
| Q4 FY2023 | Dec 31, 2023 | -1.3% | +19.1 |
| Q3 FY2023 | Sep 30, 2023 | -5.7% | +19.1 |
| Q2 FY2023 | Jun 30, 2023 | -11.8% | +23.2 |
| Q1 FY2023 | Mar 31, 2023 | -7.8% | +27.7 |
| Q4 FY2022 | Dec 31, 2022 | -20.4% | +28.1 |
| Q3 FY2022 | Sep 30, 2022 | -24.8% | +7.1 |
| Q2 FY2022 | Jun 30, 2022 | -35.0% | −18.7 |
| Q1 FY2022 | Mar 31, 2022 | -35.5% | −13.9 |
| Q4 FY2021 | Dec 31, 2021 | -48.5% | −30.7 |
| Q3 FY2021 | Sep 30, 2021 | -31.8% | −1.5 |
| Q2 FY2021 | Jun 30, 2021 | -16.3% | +20.0 |
| Q1 FY2021 | Mar 31, 2021 | -21.6% | +6.0 |
| Q4 FY2020 | Dec 31, 2020 | -17.8% | +25.8 |
| Q3 FY2020 | Sep 30, 2020 | -30.3% | −2.9 |
| Q2 FY2020 | Jun 30, 2020 | -36.4% | −25.7 |
| Q1 FY2020 | Mar 31, 2020 | -27.7% | −21.3 |
| Q4 FY2019 | Dec 31, 2019 | -43.6% | +939.9 |
| Q3 FY2019 | Sep 30, 2019 | -27.4% | −19.0 |
| Q2 FY2019 | Jun 30, 2019 | -10.7% | −12.1 |
| Q1 FY2019 | Mar 31, 2019 | -6.3% | −9.7 |
| Q4 FY2018 | Dec 31, 2018 | -983.6% | −981.9 |
| Q3 FY2018 | Sep 30, 2018 | -8.4% | −6.6 |
| Q2 FY2018 | Jun 30, 2018 | 1.4% | −6.8 |
| Q1 FY2018 | Mar 31, 2018 | 3.4% | −0.2 |
| Q4 FY2017 | Dec 31, 2017 | -1.6% | −17.5 |
| Q3 FY2017 | Sep 30, 2017 | -1.9% | −17.2 |
| Q2 FY2017 | Jun 30, 2017 | 8.2% | – |
| Q1 FY2017 | Mar 31, 2017 | 3.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 15.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 15.3% | – |
See a number that looks wrong?